CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
April 16, 2020
REMARC survival discrimination by TMTV post-RCHOP
CME
Blood (2020) 135 (16): 1411.
Article history
First Edition:
March 10, 2020
Connected Content
A related article has been published:
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
This is a related article to:
Predicting the future for DLBCL
Citation
REMARC survival discrimination by TMTV post-RCHOP. Blood 2020; 135 (16): 1411. doi: https://doi.org/10.1182/blood.2020005771
Download citation file: